Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02828618 · ClinicalTrials.gov registry record · NA
Trial on Radical Upfront Surgery in Advanced Ovarian Cancer
A NA study of Ovarian Cancer, sponsored by AGO Study Group.
- Active
- Registry status
- NA
- Development phase
- 797
- Enrollment target
- 20
- Study locations
NCT02828618 is a NA study of Ovarian Cancer that is active but no longer recruiting, run by AGO Study Group. The registered enrollment target is 797 participants, above the 726-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (10% higher). The trial reports 20 study locations across 2 states.
The verdict
NCT02828618, a NA study of Ovarian Cancer, is active but no longer recruiting, sponsored by AGO Study Group.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 797 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study consists of three parts, whereas Part 1 and Part 2 are performed in Germany only, and Part 3 is a multinational trial. All patients with suspicion of advanced ovarian cancer are detected in the participating study centers in a pre-screening. The study centers will register all patients with suspected ovarian cancer in a screening log. After the patients have given informed consent, they can be enrolled in different parts of the study. TRUST-Trial: This part compares two strategies in the therapy of advanced ovarian cancer. En detail, this part of the trial will evaluate if one of two strategies of timing surgery within the therapeutic procedures may show any significant advances in terms of overall survival over the other.
Conditions Studied
Interventions
- PROCEDURE PDS (Primary Debulkdung Surgery)
- PROCEDURE 6 cycles of standard chemotherapy
- PROCEDURE Timing of surgery after 3 cycles of standard NACT, IDS
- PROCEDURE IDS
- DRUG 3 cycles of standard chemotherapy
Study Locations (20)
Other
- Medical University of Vienna - Vienna
- University Hospital, Rigshospitalet - Copenhagen
- Institut Bergonié - Bordeaux
- Hôpital Européen Georges Pompidou (HEGP) - Paris
- Institute Gustave Roussy - Villejuif
- Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum, Klinik für Gynäkologie - Berlin
- Universitätsklinikum Carl Gustav Carus Dresden, Klinik & Poliklinik f. Frauenheilkunde & Geburtshilfe - Dresden
- Kaiserswerther Diakonie; Florence-Nightingale-Hospital - Düsseldorf
- Kliniken Essen-Mitte, Evang. Huyssens-Stiftung, Klinik für Gynäkologie und gyn. Onkologie - Essen
- Universitätsklinikum Hamburg-Eppendorf, Klinik und Poliklinik für Gynäkologie - Hamburg
- Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, Klinikum der Universität München - München
- Klinikum rechts der Isar, Frauen- und Poliklinik - München
- Universitätsklinikum Tübingen - Tübingen
- European Institute of Oncology; Gynecologic Cancer Surgery - Milan
- Fondazione IRCCS Istituto Nazionale Tumori - Milan - Milan
- Istituto Nazionale per lo Studio e la Cura dei Tumori di Napoli - Naples
- Skane University Hospital - Lund
- Karolinska University Hospital - Solna
- Imperial College London, Hammersmith Hospital, Surgery&Cancer - London
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 797 participants |
| Start Date | 2016-07 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02828618
The ClinicalTrials.gov registry entry for NCT02828618 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 797 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 726-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (10% higher). The listed sponsor is AGO Study Group, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ovarian Cancer appearing as the primary indexed condition, and to 5 interventions - of which PDS (Primary Debulkdung Surgery) is the first listed.
NCT02828618 reports 20 study locations spanning 2 distinct geographic areas - top geographies include Other, New York.
Frequently Asked Questions
What is clinical trial NCT02828618 about?
NCT02828618 is a clinical study titled "Trial on Radical Upfront Surgery in Advanced Ovarian Cancer". This study consists of three parts, whereas Part 1 and Part 2 are performed in Germany only, and Part 3 is a multinational trial. All patients with suspicion of advanced ovarian cancer are detected in the participating study centers in a pre-screening. The study centers will register all patients w...
What is the current status of trial NCT02828618?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 797 participants. The study started on 2016-07. Estimated completion is 2025-12.
What conditions does trial NCT02828618 study?
This clinical trial studies the following conditions: Ovarian Cancer.
What interventions are being tested in trial NCT02828618?
The interventions under investigation include: PDS (Primary Debulkdung Surgery) (PROCEDURE), 6 cycles of standard chemotherapy (PROCEDURE), Timing of surgery after 3 cycles of standard NACT, IDS (PROCEDURE), IDS (PROCEDURE), 3 cycles of standard chemotherapy (DRUG).
Who is sponsoring clinical trial NCT02828618?
This trial is sponsored by AGO Study Group, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02828618 being conducted?
This trial has 20 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
RECRUITING · NA
-
REVITALIZE: RCT to Reduce Fatigue in Adults With Ovarian Cancer on PARP Inhibitors
RECRUITING · NA
-
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.